인쇄하기
취소

Dong-A to face tough challenge next year

Published: 2008-12-29 07:00:00
Updated: 2008-12-29 07:00:00
The race for the generic drug market is set to be in full force in 2009.

The drug recently at the center of attention is the best-selling Stillen, a gastric membrane protector that will generate about 80 billion in this year’s sales for Dong-A Pharmaceutical.

A number of domestic firms, including Chong Kun Dang Pharmaceutical, will put out Stillen generics next year. And this quick respon...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.